Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Change in Account Payables (2024 - 2025)

Historic Change in Account Payables for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $524000.0.

  • Kestra Medical Technologies' Change in Account Payables rose 12007.66% to $524000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $815000.0, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2025, which is 6128.07% down from last year.
  • Kestra Medical Technologies' Change in Account Payables amounted to $524000.0 in Q4 2025, which was up 12007.66% from -$2.9 million recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' Change in Account Payables ranged from a high of $3.4 million in Q1 2025 and a low of -$2.9 million during Q3 2025